Drugs That Could Cut Billions From Health Costs




MarketWatch Money, Markets & More show

Summary: MarketWatch's Emma Court and Harvard Medical School's Aaron S. Kesselheim join Catey Hill and Quentin Fottrell to talk about how certain drugs, known as biosimilars, can basically replicate existing treatments and save the U.S. health care system $250 billion over the next 10 years. Learn more about your ad choices. Visit megaphone.fm/adchoices